Company / Free Cash Flow per Share
Cogent Biosciences, Inc. Free Cash Flow per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$2.06
FY2025
5-year range
-$2.14 / -$1.56
FY2021-FY2025
Trend
-2.9%
vs FY2024
Sector context
#134 of 190
Health Care
What the data says
At $-2.06, Cogent Biosciences, Inc.'s free cash flow per share ranks #134 of 190 in the Health Care sector. Free Cash Flow per Share has fluctuated over the past 8 years, ranging from $-5.45 in FY2019 to $-1.33 in FY2018.
Based on SEC 10-K filings.
-2.06 in FY2025.
Declined from $-1.96 to $-2.06 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#134 of 190 in Health CareTop 71% of 190This company -$2.06 Sector average $3.32
▼
-162.1% below sector average
Key checks
Key Insights
- In FY2025, free cash flow per share decreased 2.9% year-over-year.
- Ranks #134 out of 190 companies in the Health Care sector.
- Peak free cash flow per share was recorded in FY2018.
- Lowest free cash flow per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 0.43 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$2.06 | -2.9% |
| FY2024 | -$2.01 | -2.2% |
| FY2023 | -$1.96 | +8.1% |
| FY2022 | -$2.14 | -36.8% |
| FY2021 | -$1.56 | - |
| FY2020 | - | - |
| FY2019 | -$5.45 | -310.9% |
| FY2018 | -$1.33 | +49.4% |
| FY2017 | -$2.62 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026